A Disease-Specific DNA Chip for von Willebrand Disease
Platelets as Modifiers of Phenotype in Hemophilia A
Self-Regulating HIV Vectors for Hemophilia A Gene Therapy
Events
Pharmacogenomics of Hemophilia Therapy: Genetics of Inhibitor Antibody Response
Immune Response in Platelet-Derived FVIII Gene Therapy of Murine Hemophilia A
Recombinant Factor VIIa and RL Platelets as a Hemophilia Therapy
Studies of VWF Function in VWF-Platelet and VWF-FVIII Interactions
Dr. Flood earned her undergraduate degree from Harvard University in 1995 and her doctorate from Tufts University in 1999. She is board certified in pediatrics as well as pediatric hematology/oncology. She has been serving as an Assistant Professor…
Identification and Amelioration of T-cell Mediated Inflammatory Cytokines that Contribute to Anti-Factor VIII Inhibitor Formation in Hemophilia A
Dr. Smith's research focuses on better understanding the development of factor VIII inhibitors. Specifically, she will focus on the effects of chemical signals, or cytokines, secreted by helper T cells on the development of inhibitor antibodies. She…
The Red Thread: 75th Anniversary Celebration
Established in 1948, the National Bleeding Disorders Foundation has long been one of the nation’s leading organizations dedicated to serving patients and families living with inheritable blood and bleeding disorders such as hemophilia, von…